The Terri Brodeur Breast Cancer Foundation has awarded $300,000 in grants to three researchers who are looking for a cure for breast cancer and better ways to treat the disease in those already diagnosed.
The foundation's scientific advisory board chaired by founding member Nicholas Saccomano, PhD, reviewed applications and conducted telephone interviews with the top six.
"Our foundation asks a great deal of our awardees and their respective institutes. 100% of gross funds must go directly to activities focused on high impact areas of clinical and preclinical breast cancer therapeutic research," Saccomano said.
The 2022 grant recipients are:
In addition to Saccomano, who is a chief scientific officer and senior vice president at Pfizer Boulder Research and Development, and LaMattina, the former president of Pfizer Global Research and Development, the advisory board includes Michael Garabedian, PhD, professor and course director at New York University Medical Center; Susan Logan, PhD, associate professor at New York University Medical Center; and Michael Morin, PhD, chief executive officer of Immunome Inc. All are founding members of TBBCF.
Each year the foundation raises money for the grants with its Walk for a Cure marathon and with donations from cancer survivors, community members, and businesses, who support the TBBCF mission of giving 100 percent of its fundraising dollars to breast cancer research. Since its founding in 2006, the New London-based foundation has raised $5.5 million and awarded grants to 55 researchers just starting out in their careers.
"In a time where good news is always welcomed, sharing the persistence of a grassroots foundation to fund young scientists and a hope for the future, is a delight," Saccomano shared.
The 2022 research fellows, who will each receive $100,000 grants, will spend the next two years working on their projects.
Visit our Granting Process page to learn more about how grant recipients are chosen every year.
Click here to learn more about the grant recipients TBBCF has funded over the years.